UY36086A - QUINOXALINE COMPOUNDS AND USES OF THE SAME - Google Patents
QUINOXALINE COMPOUNDS AND USES OF THE SAMEInfo
- Publication number
- UY36086A UY36086A UY0001036086A UY36086A UY36086A UY 36086 A UY36086 A UY 36086A UY 0001036086 A UY0001036086 A UY 0001036086A UY 36086 A UY36086 A UY 36086A UY 36086 A UY36086 A UY 36086A
- Authority
- UY
- Uruguay
- Prior art keywords
- same
- quinoxaline compounds
- compounds
- subsets
- quinoxaline
- Prior art date
Links
Abstract
La invención proporciona compuestos de fórmula I y subconjuntos de los mismos: donde T, J, R, R (a la 4), R (a la q), o, R (a al A) y R (a la B) y los subconjuntos de los mismos son tales como se describen en la memoria descriptiva. 10 Los compuestos son inhibidores de NAMPT, y por consiguiente, son útiles para el tratamiento del cáncer, afecciones inflamatorias y enfermedades autoinmunes mediadas por células T.The invention provides compounds of formula I and subsets thereof: where T, J, R, R (at 4), R (at q), or, R (a at A) and R (at B) and The subsets thereof are as described in the specification. The compounds are NAMPT inhibitors, and therefore, are useful for the treatment of cancer, inflammatory conditions and autoimmune diseases mediated by T cells.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461981273P | 2014-04-18 | 2014-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY36086A true UY36086A (en) | 2015-11-30 |
Family
ID=55018090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001036086A UY36086A (en) | 2014-04-18 | 2015-04-17 | QUINOXALINE COMPOUNDS AND USES OF THE SAME |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR100136A1 (en) |
UY (1) | UY36086A (en) |
-
2015
- 2015-04-17 AR ARP150101176A patent/AR100136A1/en unknown
- 2015-04-17 UY UY0001036086A patent/UY36086A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR100136A1 (en) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018007528A2 (en) | Heterocyclic compounds as immunomodulators | |
CO2019008783A2 (en) | Cyclic dinucleotide compounds for the treatment of cancer | |
CL2018001230A1 (en) | Osteoarthritis treatment | |
ECSP19003773A (en) | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | |
CO2018006662A2 (en) | Apeline receptor agonists and methods of use | |
CL2017002786A1 (en) | Cross reference to related requests | |
CL2017003404A1 (en) | Antibacterial compounds | |
CL2018003123A1 (en) | Combination therapy for cancer treatment | |
SV2017005424A (en) | METHODS TO TREAT INFECTIONS BY VIRUS FILOVIRIDAE | |
CL2017000712A1 (en) | Pyrimidinones as inhibitors of factor xia | |
CO2017004525A2 (en) | Ror-gamma inhibitory dihydropyrrolopyridines | |
CL2016002394A1 (en) | Quinoline derivatives as smo inhibitors | |
CL2016002027A1 (en) | Cyclopropylamine as an inhibitor of lsd1 | |
UY34657A (en) | ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?. | |
CL2018001621A1 (en) | Heteroarylhydroxypyrimidinones as apeline receptor agonists (apj) | |
EA201792205A1 (en) | HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS | |
CL2017000792A1 (en) | Boronic Acid Derivatives | |
EA201691594A1 (en) | CYCLOPROPYLAMINES AS LSD1 INHIBITORS | |
CL2018000953A1 (en) | Compuestos derivados de 2,4-dihidroxi-nicotinamidas, agonistas del receptor de apelina (apj); composicion farmaceutica que los comprende; uso en el tratamiento de enfermedades cardiovasculares. | |
CL2015003089A1 (en) | Bicyclic heterocycles as fgfr inhibitors. | |
UY34750A (en) | ? COMPOUNDS FOR HIV TREATMENT, COMPOSITIONS, PREPARATION METHODS, INTERMEDIARIES AND THERAPEUTIC METHODS ?. | |
AR101905A1 (en) | BICYCLIC COMPOUNDS | |
UY34201A (en) | AZAINDOL COMPOUNDS AND METHODS FOR HIV TREATMENT. | |
ECSP18012103A (en) | COLONY STIMULATING FACTOR RECEPTOR 1 (CSF-1R) INHIBITORS | |
CL2018001569A1 (en) | Heteroaromatic compounds as btk inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20220617 |